- Report
- March 2024
- 186 Pages
Global
From €3207EUR$3,374USD£2,743GBP
€3564EUR$3,749USD£3,048GBP
- Report
- November 2023
- 175 Pages
Global
From €4753EUR$5,000USD£4,065GBP
- Report
- November 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,943GBP
- Report
- March 2024
- 93 Pages
Global
From €5323EUR$5,600USD£4,553GBP
- Report
- March 2024
- 94 Pages
Global
From €5323EUR$5,600USD£4,553GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,374GBP
- Report
- January 2024
- 285 Pages
Global
From €9031EUR$9,500USD£7,723GBP
- Report
- January 2024
- 142 Pages
Global
From €4515EUR$4,750USD£3,862GBP
- Report
- October 2023
- 178 Pages
Global
From €4658EUR$4,900USD£3,983GBP
- Report
- February 2024
- 115 Pages
Global
From €4064EUR$4,275USD£3,475GBP
€4515EUR$4,750USD£3,862GBP
- Report
- March 2024
- 195 Pages
Global
From €3207EUR$3,374USD£2,743GBP
€3564EUR$3,749USD£3,048GBP
- Report
- March 2024
- 185 Pages
Global
From €3207EUR$3,374USD£2,743GBP
€3564EUR$3,749USD£3,048GBP
- Report
- March 2024
- 189 Pages
Global
From €3207EUR$3,374USD£2,743GBP
€3564EUR$3,749USD£3,048GBP
- Report
- February 2024
- 175 Pages
Global
From €4753EUR$5,000USD£4,065GBP
- Report
- March 2024
- 898 Pages
Global
From €5323EUR$5,600USD£4,553GBP
- Report
- February 2024
- 184 Pages
Global
From €3422EUR$3,600USD£2,927GBP
- Report
- February 2024
- 193 Pages
Global
From €3422EUR$3,600USD£2,927GBP
- Clinical Trials
- February 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,626GBP
- Drug Pipelines
- July 2023
- 139 Pages
Global
From €10452EUR$10,995USD£8,938GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4706EUR$4,950USD£4,024GBP
The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more